Search
for
Sort by
Research 601–630 of 771
- Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
- Baricitinib Induced Hypoglycemic Seizures in a Patient with Hair Loss and Type I Diabetes Mellitus: A Case Report
- Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- 448 Combined therapeutic approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- Spotlight in Plastic Surgery: October 2022
- 056 IL-15 prolongs hair growth and operates as a guardian of human hair follicle immune privilege
- Tofacitinib citrate alleviates alopecia universalis symptoms in recent case study
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib